KAS
HRMY icon

Kemnay Advisory Services’s Harmony Biosciences HRMY Stock Holding History

Kemnay Advisory Services’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1K Buy
+443
New +$14K ﹤0.01% 861

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kemnay Advisory Services's HRMY Position: Q2 2026 in Review

Kemnay Advisory Services opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 443 shares worth $16.1K. The stake represents ﹤0.01% of the portfolio and ranks #861 among its holdings.

326 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Kemnay Advisory Services held 443 shares of Harmony Biosciences worth $16.1K as of Q2 2026.
  • Harmony Biosciences was a new Kemnay Advisory Services position in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #861 holding.
  • 326 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.